| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |